Navigation Links
Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs
Date:12/3/2013

h Center of Pittsburgh, a clinical fellowship in medical oncology at Johns Hopkins Oncology Center and a clinical fellowship in hematology at Beth Israel Hospital in Boston. He then held a postdoctoral fellowship in cellular and developmental biology at Harvard University before joining Fox Chase.  Dr. Chernoff has chaired numerous international meetings and serves as an editor for Molecular Cell Biology, as well as a frequent ad-hoc reviewer for many top-tier science journals.

Dr. Chernoff stated, "Working at one of the nation's forty-one NCI-designated Comprehensive Cancer Centers, I have made a career in cancer research and treatment with the goal of improving therapies in solid tumors. Among its many differentiating factors, Enteris and its proprietary oral delivery technology platform offer the potential to greatly improve chemotherapy treatments by enabling a number of very effective cytotoxic and targeted agents that currently require IV administration to be delivered orally."

Dr. Danho joins Enteris as one of the foremost leaders in the discovery of peptide-based drugs, peptide mimetics, and conformationally restricted peptides.  Most recently the Distinguished Research Leader at Hoffmann-La Roche Inc., Dr. Danho currently serves as a council member of the American Peptide Society and is reviewer for the Journal of Peptide Research, QSAR & Combinatorial Science, as well as for the Journal of Medicinal Chemistry; he is a member of the editorial board of The International Journal of Peptide Research and Therapeutics. During his career, Dr. Danho authored and co-authored more than 250 scientific articles and 21 patents in the field of peptides and has presented and chaired various sections of the American, European and International Peptide Symposia since 1972.  Dr. Danho completed his Ph.D. in 1967 at the University of Aachen, Aachen, '/>"/>

SOURCE Enteris BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Enteris BioPharma and Nordic BioSciences KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris Proprietary Oral Drug Delivery and Manufacturing Platform
2. Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics
3. Therapure Biopharma Inc. has Acquired Plasma Protein Purification Technology From Upfront Chromatography A/S
4. PDL BioPharma to Present at the 25th Annual Piper Jaffray Healthcare Conference
5. UCLA Venture Capital Fund Selects KYTHERA Biopharmaceuticals CEO Keith Leonard for First Annual Entrepreneurial Achievement Award
6. IPO, Earnings & Corporate Developments: Twitter, Vale SA, OCZ Technology Group, Radian Group, Keryx Biopharmaceuticals
7. TransCelerate BioPharma Inc. Launches Second Year Initiatives, Expands Membership and Achieves Milestones for Original Projects
8. Biopharmaceuticals - A Global Market Overview
9. Can-Fite BioPharma to Conduct European Road Show
10. MGB Biopharma to Present at Bio-Europe 2013
11. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 2014 Sleep disturbances such as ... correlated with depression. According to a study published ... three quarters of depressed patients have insomnia symptoms, ... young depressed adults and 10% of older patients, ... huge distress, have a major impact on quality ...
(Date:7/18/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... operating officer and president, has resigned, effective July 31, ... consultant going forward on special projects. His resignation is ... this position since September 2013. On an interim basis, ... , who has been Neogen,s chief executive officer since ...
(Date:7/18/2014)... (PRWEB) July 18, 2014 Global ... with US offices in Cambridge, MA, announces the ... Assay and Software product that leverages the power ... the Illumina® MiSeq sequencing platform. The assay and ... Children’s Hospital of Philadelphia (CHOP) and will include ...
(Date:7/18/2014)... 2014 Provia Laboratories announces the addition ... Board. Dr. Vaught has worked in the field ... As one of the founding members of ISBER ... - in 1999, he served as its second president, ... In 2005, Dr. Vaught began working with the National ...
Breaking Biology Technology:Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 2Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 3
... NEW HAVEN, Conn., Aug. 5 Rib-X Pharmaceuticals, Inc. ... discovery, development and commercialization of novel antibiotics for the treatment ... 2 clinical trial of radezolid in the treatment of community-acquired ... double-blind study, radezolid was administered orally at three different doses: ...
... , SANTA MONICA, Calif., Aug. 5 Cord ... stem cell preservation company ( http://www.cordblood-america.com ) ... families nationwide and internationally, said today it has retired $2.53M of ... in February and March of 2007 respectively, between CBAI and the ...
... ... medical exposition of its kind. John Rizvi will deliver a presentation titled, "Preservation of ... , ... 5, 2009 -- On August 13, 2009 at 1:00 PM, attorney John Rizvi will deliver ...
Cached Biology Technology:Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia 2Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia 3Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia 4Cord Blood America Retires $2.53M Obligation 2Cord Blood America Retires $2.53M Obligation 3Patent Attorney John Rizvi Speaks at FIME International Medical Expo 2
(Date:7/21/2014)... Saudi Arabian researchers have detected genetic fragments of Middle ... a barn holding a camel infected with the virus. ... the online open-access journal of the American Society for ... if the disease can be transmitted through the air. ... the coronavirus, has been identified in 699 people as ...
(Date:7/21/2014)... issued a high health risk warning for Yellowknife and ... due to forest fires. Currently 160 wildfires are ... for evacuation since these fires are endangering people or ... recently comes with mixed results. The rains help ... start others. , This year the Northern Territories have ...
(Date:7/21/2014)... A team of University of California, Riverside Bourns College ... under the grates of a backyard grill reduces by 70 ... , The one-eighth inch thick steel carbon plate with an ... cutting a slit into the grill to allow the plate ... adopted by grill manufacturers who could sell new grills with ...
Breaking Biology News(10 mins):Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2Catching grease to cut grill pollution 2
... research professor and professor emeritus at The University of ... the American Academy of Arts & Sciences (AAAS), along ... Earl Jones, U.S. Secretary of Defense Robert Gates and ... scientist who translates his discoveries into technology that helps ...
... New York Sea Grant (NYSG) announces the release of ... Populations in South Shore Bays of Long Island, NY, ... of five research projects funded through NYSG,s Hard Clam ... NOAA National Marine Fisheries Service, South Shore Estuary Reserve, ...
... In Maine, government scientists have figured out how to measure ... and the sun - all the while saving money, energy, ... this energy-efficient ingenuity was the need to help the National ... spring snowmelt. The problem was this: While the USGS ...
Cached Biology News:University of Texas at Austin engineer elected to American Academy of Arts and Sciences 2University of Texas at Austin engineer elected to American Academy of Arts and Sciences 3Sea Grant report synthesizes recent research on New York's clams 2Measuring snow with a bucket, a windmill, and the sun? 2
RABBIT ANTI HUMAN APP (KP1 DOMAIN) Immunogen: Synthetic peptide composed of amino acids 292-312 from the KPI domain of human APP....
Request Info...
... 3243 provides all the materials necessary for the ... CMV antigen studies analysis. Kit Components: ... No. 5122) One bottle containing 220 mL of ... Solution (5X) - (Catalog No. 5113) One bottle ...
... suspension (non-adherent) cells, RNA ture ... or centrifugation to separate cells ... with 96-well GenePlate®. RiboCap™ plates ... sizes and contain the appropriate ...
Biology Products: